RadNet's Record-Breaking Q1 2026: Severe Weather Can't Stop the Company's Momentum

RadNet's Record-Breaking Q1 2026: Severe Weather Can't Stop the Company's Momentum


RadNet, Inc., a leading provider of outpatient diagnostic imaging services throughout the United States, has released its first quarter 2026 financial results, showcasing a record-breaking performance despite facing severe weather conditions on the East Coast.

According to Dr. Howard Berger, Executive Vice President and Chief Financial Officer, revenue and adjusted EBITDA were significantly impacted by an estimated $13 million of revenue and $9 million adjusted EBITDA from the harsh weather in January and February. However, despite this setback, RadNet's first quarter results still managed to outshine last year's performance.

The company reported a 22.1% increase in revenue and a 36.3% jump in adjusted EBITDA compared to the same period in 2025. This achievement is even more impressive when considering that last year's first quarter was also affected by severe weather conditions on the East Coast, as well as the Southern California wildfires.

When adjusting for these external factors, RadNet's margin improved by a remarkable 52 basis points, demonstrating the company's resilience and ability to adapt to challenging circumstances. The strong performance is also attributed to the growing demand for advanced imaging services, with 29.3% of procedural volume coming from advanced imaging this year, compared to 26.9% in the same period last year.

The implementation of TechLive, a remote scanning solution for technologists, has significantly benefited RadNet's MRI utilization by reducing exam room closure hours. This strategic initiative aligns with the company's focus on leveraging technology to enhance patient care and improve operational efficiency.

PET/CT procedure growth continues to be driven by studies related to cancer identification and staging, as well as brain plaque detection correlated with Alzheimer's and dementia. The quarter witnessed a 35.2% increase in aggregate PET/CT procedures and a 14.7% rise on a same-center basis.

RadNet's strong March performance has continued into April and May, surpassing internal projections for the first quarter embedded in its 2026 full-year guidance. This sustained momentum is a testament to the company's operational strength and ability to navigate unforeseen challenges.

Read more